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the necrotic core. It was suggested that patients with plaques
exhibiting these characteristics might benefit from selective use of
distal protection devices. Neither study suggested that a relation-
ship exists between original plaque volume and the occurrence of
embolization.
In our opinion, these studies have a number of limitations.
Kawaguchi et al. (1) chose ST-segment re-elevation immediately
after stent implantation as a proxy for embolization. This param-
eter has not previously been linked to the more recognized end
points of myocardial blush grade or 90-min ST-segment resolution
(3). Additionally, the limited ability of the 20-MHz Eagle Eye
IVUS catheter (Volcano Therapeutics, San Diego, California) to
identify luminal thrombus may be particularly relevant in their
patients who received only aspirin as a procedural antiplatelet
therapy. Moreover, the possibility of side branch occlusion during
stent deployment as a cause of myocardial necrosis does not appear
to have been considered. In patients with stable angina, Kawamoto
et al. (2) suggested that plaques with larger necrotic cores were
more likely to exhibit high-intensity transient signals detected by a
Doppler guidewire. Histopathological correlates between VH-IVUS
and pathology are questionable, and neither study uses post-
procedure IVUS imaging of residual plaque. Using 40-MHz IVUS
imaging, a direct relationship has been demonstrated between the
change in plaque volume and evidence of new myocardial necrosis
(4). Thus, although it is perhaps intuitive that friable plaque
elements are more likely to be liberated than are more readily
compressed fibrotic components, further investigation is required.
In the accompanying editorial, Shah (5) questions whether no
reflow is merely a marker of myocardial injury or whether it is the
cause of further myocardial damage. There is currently no data to
support the notion that, in established no reflow, administration of
any pharmacologic agent has any impact on subsequent prognosis,
and perfusion in areas of new myocardial necrosis remains im-
paired for at least 24 h despite normal perfusion in viable areas of
myocardium subtended by the same vessel (6). These data suggest
that no reflow is predominantly a marker of downstream myocar-
dial necrosis. As more diffuse and challenging diseases are being
tackled by percutaneous coronary intervention (PCI), further
research into the prevention of plaque embolization is essential to
allow further improvement in PCI outcomes.
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Reply
We appreciate the interest in our recent study (1) by Dr. Porto and
colleagues. Myocardial blush grade (MBG) and early ST-segment
resolution are well-known parameters used for describing the
effectiveness of myocardial reperfusion, which is an independent
predictor of long-term mortality (2). However, the aim of our
study was to investigate distal embolization that occurs immedi-
ately after stent implantation: in other words, distal embolization
induced by stent implantation. Although stent-induced distal
embolization is one of the causes of low blush grade or early
ST-segment resolution, it is not the only cause—several factors
such as vasoconstriction, additional pharmacologic therapy, and
time interval after stent implantation may also affect the outcome
of these parameters. Because we were not investigating final
coronary flow and prognosis, we believed that we did not need to
consider the relationship between ST-segment re-elevation (STR)
and MBG or early ST-segment resolution. Thus far, we have not
come across parameters specific to estimating the extent of
stent-induced distal embolization, and certainly, as we mentioned
in the limitations section, we need to validate our measurements in
a different cohort to see how the predictive algorithm correlates
with STR. However, STR during percutaneous coronary interven-
tion is recognized as a predictor of the no-reflow phenomenon
(3,4). In the no-reflow cases, distal embolization of the plaque or
thrombus from the lesion site is a likely mechanism (5,6). There-
fore, distal embolization of the plaque or thrombus from the lesion
site induced by stent deployment is the probable cause of STR.
Based on these data, we believe that STR occurring immediately
after stent implantation reflects distal embolization induced by
stent implantation.
We had mentioned in the limitations section about the presence
of residual luminal thrombus and the ability of the 20-MHz
intravascular ultrasound catheter to assess the plaque component.
Moreover, we did not have any cases with side branch occlusion in
the 11 STR cases, and it should have been included in the
exclusion criteria of our study.
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